早期乳腺癌最佳辅助化疗和靶向治疗的选择：美国临床肿瘤学会临床实践指南重点更新摘要 - Suppr

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update Summary.

作者信息

Denduluri Neelima, Somerfield Mark R, Giordano Sharon H

机构信息

Virginia Cancer Specialists, the US Oncology Network, Arlington, VA; American Society of Clinical Oncology, Alexandria, VA; University of Texas MD Anderson Cancer Center, Houston, TX.

出版信息

J Oncol Pract. 2018 Aug;14(8):508-510. doi: 10.1200/JOP.18.00207. Epub 2018 Jun 20.

DOI:10.1200/JOP.18.00207

PMID:29924666

Abstract

摘要

相似文献

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update Summary.早期乳腺癌最佳辅助化疗和靶向治疗的选择：美国临床肿瘤学会临床实践指南重点更新摘要

J Oncol Pract. 2018 Aug;14(8):508-510. doi: 10.1200/JOP.18.00207. Epub 2018 Jun 20.

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.使用生物标志物指导早期浸润性乳腺癌女性辅助全身治疗决策：美国临床肿瘤学会临床实践指南重点更新

J Clin Oncol. 2017 Aug 20;35(24):2838-2847. doi: 10.1200/JCO.2017.74.0472. Epub 2017 Jul 10.

Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline.人表皮生长因子受体 2（HER2）阴性乳腺癌的最佳辅助化疗方案选择和 HER2 阳性乳腺癌的辅助靶向治疗：美国临床肿瘤学会指南对加拿大安大略省癌症护理临床实践指南的改编。

J Clin Oncol. 2016 Jul 10;34(20):2416-27. doi: 10.1200/JCO.2016.67.0182. Epub 2016 Apr 18.

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Focused Update Guideline Summary.使用生物标志物指导早期浸润性乳腺癌女性辅助性全身治疗的决策：美国临床肿瘤学会临床实践重点更新指南摘要

J Oncol Pract. 2017 Nov;13(11):763-766. doi: 10.1200/JOP.2017.024646. Epub 2017 Jul 11.

New practice-changing study findings presented at ASCO.

JAMA. 2014 Jul 16;312(3):218-9. doi: 10.1001/jama.2014.7708.

Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer-Cyclin-Dependent Kinase 4 and 6 Inhibitors: ASCO Guideline Rapid Recommendation Update.早期乳腺癌的最佳辅助化疗和靶向治疗——细胞周期蛋白依赖性激酶 4 和 6 抑制剂：ASCO 指南快速推荐更新。

J Clin Oncol. 2024 Jun 20;42(18):2233-2235. doi: 10.1200/JCO.24.00886. Epub 2024 May 20.

Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline Update Summary.晚期人表皮生长因子受体2阳性乳腺癌患者的全身治疗：美国临床肿瘤学会临床实践指南更新摘要

J Oncol Pract. 2018 Aug;14(8):501-504. doi: 10.1200/JOP.18.00290. Epub 2018 Jul 10.

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update.Ⅰ期至ⅢA 期完全切除的非小细胞肺癌的辅助全身治疗和辅助放疗：美国临床肿瘤学会/安大略癌症护理临床实践指南更新。

J Clin Oncol. 2017 Sep 1;35(25):2960-2974. doi: 10.1200/JCO.2017.72.4401. Epub 2017 Apr 24.

Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.局部晚期非小细胞肺癌的根治性和辅助放疗：美国临床肿瘤学会临床实践指南对美国放射肿瘤学会循证临床实践指南的认可。

J Clin Oncol. 2015 Jun 20;33(18):2100-5. doi: 10.1200/JCO.2014.59.2360. Epub 2015 May 5.

Perspectives from the American Society of Clinical Oncology 2014 Conference: breast cancer highlights.美国临床肿瘤学会2014年会议观点：乳腺癌要点

Future Oncol. 2014 Oct;10(12):1897-9. doi: 10.2217/fon.14.151.

引用本文的文献

Value of UGT2B7-161 Single Nucleotide Polymorphism in Predicting the Risk of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Who Underwent Pertuzumab Combined with Trastuzumab Therapy by PSL.UGT2B7-161单核苷酸多态性在预测接受帕妥珠单抗联合曲妥珠单抗治疗的HER-2阳性乳腺癌患者发生心脏毒性风险中的价值。

Pharmgenomics Pers Med. 2022 Mar 15;15:215-225. doi: 10.2147/PGPM.S351718. eCollection 2022.

Antibody-Drug Conjugates for the Treatment of Breast Cancer.用于治疗乳腺癌的抗体药物偶联物

Cancers (Basel). 2021 Jun 9;13(12):2898. doi: 10.3390/cancers13122898.

Prognostic and predictive parameters in breast pathology: a pathologist's primer.乳腺病理学中的预后和预测参数：病理学家入门。

Mod Pathol. 2021 Jan;34(Suppl 1):94-106. doi: 10.1038/s41379-020-00704-7. Epub 2020 Nov 5.

Quality and reporting of clinical guidelines for breast cancer treatment: A systematic review.乳腺癌治疗临床指南的质量和报告：系统评价。

Breast. 2020 Oct;53:201-211. doi: 10.1016/j.breast.2020.07.011. Epub 2020 Aug 10.

Optimal Systemic Treatment for Early Triple-Negative Breast Cancer.早期三阴性乳腺癌的最佳全身治疗

Breast Care (Basel). 2020 Jun;15(3):217-226. doi: 10.1159/000508759. Epub 2020 Jun 2.

Shared decision making in breast cancer treatment guidelines: Development of a quality assessment tool and a systematic review.乳腺癌治疗指南中的共同决策：质量评估工具的制定和系统评价。

Health Expect. 2020 Oct;23(5):1045-1064. doi: 10.1111/hex.13112. Epub 2020 Aug 3.

ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers.ERCC1是早期或局部晚期乳腺癌中蒽环类药物耐药和紫杉烷敏感性的预测指标。

Cancers (Basel). 2019 Aug 10;11(8):1149. doi: 10.3390/cancers11081149.

PERSEPHONE: are we ready to de-escalate adjuvant trastuzumab for HER2-positive breast cancer?珀尔塞福涅：我们准备好降低HER2阳性乳腺癌辅助曲妥珠单抗的使用强度了吗？

NPJ Breast Cancer. 2019 Jan 4;5:1. doi: 10.1038/s41523-018-0098-y. eCollection 2019.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update Summary.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献